Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.

[1]  E. Braunwald,et al.  Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. , 1985, The Journal of clinical investigation.

[2]  E. Braunwald,et al.  Evaluating the efficacy of new inotropic agents. , 1984, Journal of the American College of Cardiology.

[3]  E. Braunwald,et al.  Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. , 1983, The New England journal of medicine.

[4]  E. Sonnenblick,et al.  Sustained Hemodynamic and Clinical Effects of a New Cardiotonic Agent, WIN 47203, in Patients with Severe Congestive Heart Failure , 1983, Circulation.

[5]  R. Magorien,et al.  Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure. , 1983, Journal of the American College of Cardiology.

[6]  J. Bristow,et al.  Myocardial Lactate Extraction: Multi‐determined Metabolic Function , 1980, Circulation.

[7]  J I Hoffman,et al.  Determinants and prediction of transmural myocardial perfusion. , 1978, Circulation.

[8]  H. Loeb,et al.  Superiority of Dobutamine over Dopamine for Augmentation of Cardiac Output in Patients with Chronic Low Output Cardiac Failure , 1977, Circulation.

[9]  R. Tuttle,et al.  Dobutamine: DEVELOPMENT OF A NEW CATECHOLAMINE TO SELECTIVELY INCREASE CARDIAC CONTRACTILITY , 1975, Circulation research.

[10]  E. Braunwald,et al.  Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs. , 1974, The Journal of clinical investigation.

[11]  D. Nutter,et al.  In Vivo Analysis of Adrenergic Receptor Activity of Dobutamine , 1974, Circulation Research.

[12]  J. Mitchell,et al.  Changes in left ventricular function produced by the injection of contrast media. , 1972, American heart journal.

[13]  H. Swan,et al.  Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man , 1971, Circulation.

[14]  E. Braunwald,et al.  Control of myocardial oxygen consumption: physiologic and clinical considerations. , 1971, The American journal of cardiology.

[15]  J. Ross,et al.  Control of myocardial oxygen consumption: relative influence of contractile state and tension development. , 1968, The Journal of clinical investigation.

[16]  J. P. Gilmore,et al.  Inotropic augmentation of myocardial oxygen consumption. , 1967, The American journal of physiology.

[17]  Mcdonald Rh,et al.  Measurement of myocardial developed tension and its relation to oxygen consumption. , 1966 .

[18]  R. F. Shaw,et al.  Control of Coronary Blood Flow by an Autoregulatory Mechanism , 1964, Circulation research.

[19]  J. Mitchell,et al.  Hemodynamic determinants of the maximal rate of rise of left ventricular pressure. , 1963, The American journal of physiology.

[20]  E. Braunwald,et al.  Studies on the first derivative of the ventricular pressure pulse in man. , 1962, The Journal of clinical investigation.